Abstract
Much has been written about the impact of deep vein thrombosis (DVT) on the current health system. Recommendations have been developed and implemented for prophylaxis and treatment of DVT, but in spite of these, it continues to significantly contribute to patient morbidity and mortality, creating a large burden on people and systems. Despite evidence available from numerous trials of thromboprophylactic methods comparing anticoagulants and mechanical therapies, debate still exists about what is the safest and most cost-effective intervention. If used appropriately, prophylaxis prevents the hospital and patient from costly diagnostic procedures and prolonged anticoagulation therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
